Total Funding
82
35
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
849115
Metheor Therapeutics is a biotechnology company designing and developing inhibitors of DNA methyltransferase enzymes.
About the Company
Metheor Therapeutics Corp is a biotechnology company designing and developing inhibitors of DNA methyltransferase enzymes (DNMTs). Our goal is to produce novel therapeutic compounds that will have a role in the treatment of cancers and other major diseases. While there are two approved DNMT inhibitors being used to treat Myelodysplastic Syndromes
(Vidaza and Dacogen), there is a need for new treatments with selective pharmocology and improved toxicity profiles. Our novel approach addresses this need.
